Small Biotechs, Big Decisions
Stay tuned for Season 2 of our limited podcast series exploring the challenges and opportunities facing emerging biotech companies.
PODCAST: SMALL BIOTECHS, BIG DECISIONS
Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP, Thought Leadership, Norstella and Claire Riches, VP, Clinical Solutions, Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation.
Get the full picture and start listening today.
Listen now
WATCH THE VIDEO SERIES
Each episode begins with a 1-minute highlight and continues into a full discussion of strategic insights for biotech leaders.
How to Survive Innovation Pressure in Today's Biotech Landscape
Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resilience are rising. This episode explores how biotechs ignite innovation despite economic headwinds, regulatory uncertainty, and fierce competition.
OTHER WAYS TO LISTEN:
Strategies to Secure Critical Biotech Funding Amid Market Challenges
Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping drug development. Is reinvention biotech's last hope?
OTHER WAYS TO LISTEN:
How to Crush Competitive Threats and Stand Out in Biotech
The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsmart rivals and change the game.
OTHER WAYS TO LISTEN:
Master Regulatory Hurdles and Accelerate Your Drug Development
With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing real-world data, and finding new global pathways to bring therapies to life.
OTHER WAYS TO LISTEN:
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy, IQVIA Biotech, share the secrets behind winning biotech-CRO partnerships, covering collaboration, transparent budgeting, regulatory navigation, and recruitment strategies, with essential insights to help biotechs succeed from their first RFP to global trials.
OTHER WAYS TO LISTEN:
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
Biotech funding is tougher than ever — but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success.
OTHER WAYS TO LISTEN:
MEET Claire Riches & Daniel Chancellor
Claire Riches, VP, Clinical Solutions, Citeline
Claire Riches brings over 25 years of pharma experience to help biotech teams run faster, smarter trials. At Citeline, she leads with deep expertise in clinical research, commercial strategy, and therapeutic leadership, turning complex data into clear, AI-driven clinical solutions. Claire is passionate about using data and AI to drive better decisions particularly in patient recruitment, trial diversity, and increasing the chances of success.
Daniel Chancellor, VP, Thought Leadership, Norstella
Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing unique research that guides clients through ever-changing industry dynamics. He regularly participates in webinars and conferences providing expert insights across leading industry publications.
FLEXIBLE BIOTECH PACKAGES FOR EVERY STAGE
Discover how to reduce risk, accelerate progress, and make smarter decisions at every step.
Pre-IND Accelerator
Accelerate Your IND Approval
- Data-driven IND strategy
- Robust protocol & clinical planning
- Reduced regulatory back-and-forth
- Tailored to your asset & budget
- Expert SME guidance
Clinical Planning & Study Start-up
Launch with Precision
- Strategic trial positioning
- Robust protocol & site selection
- Budget & timeline clarity
- Expert KOL network development
- Agile SME support
Clinical Strategy & Validation
Smarter Path to Trial Success
- Strategic CRO partner validation
- Data-driven strategy optimization
- Accelerated enrollment strategies
- Investor & regulatory ready outputs
- Agile SME validation support
Your accelerated path to biotech success begins here.
Partner with us for bespoke strategic expertise built around your goals, your timeline, and your budget.
At Citeline and Evaluate, we deliver trusted clinical and commercial intelligence with expert support, helping you move faster and make smarter decisions.
